Tuesday, December 22, 2020

New radionuclide enables PET imaging of targeted alpha cancer therapies

New radionuclide enables PET imaging of targeted alpha cancer therapies: Cerium-134 enables imaging of alpha emitters that can treat cancer and spare patients negative side effects

No comments:

Post a Comment